Gossamer bio announces appointment of faheem hasnain as chief executive officer

San diego--(business wire)--gossamer bio, inc. (nasdaq: goss), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that the company's board of directors has appointed faheem hasnain as chief executive officer and president, effective immediately. mr. hasnain is a co-founder, former chief executive officer, and current chairman of gossamer bio. mr.
GOSS Ratings Summary
GOSS Quant Ranking